Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

webinar

Thu, 27 Oct 2022, 16:00 CEST (Berlin)

Dr. Xavier Morelli, Centre de Recherche en Cancérologie de Marseille (CRCM), France

Integrated Strategy for Hit-to-Lead Optimization: The ‘DOTS’ approach

In recent decades, the identification of hits has been greatly facilitated by advances in high throughput screening (HTS) and the design of chemical libraries. It would be wishful to optimize the automation of the ‘hit-to-lead’ (H2L) process. Xavier will present an integrated strategy for the H2L optimization phase and the automated design of chemical probes called Diversity Oriented Target-Focused Synthesis (DOTS and CovaDOTS) approach.
In the ‘DOTS’ approach, a focused virtual library is generated by combining an activated fragment — corresponding to a substructure that binds to a target — with a collection of functionalized chemical blocks, using in silico encoded relevant chemical reactions. Target-specific compounds are selected by virtual screening, followed by in vitro synthesis and evaluation using a robotic platform. The proof of concept was successfully completed by the optimization of bromodomain inhibitors that lead to the validation of several compounds with an affinity that had improved by several orders of magnitude. The proposed process can be implemented in academic environments or biotechnology companies that desire an automation of these processes.

 

Register and tune in for a very exciting webinar.

1 Hoffer L. et al. J. Med. Chem. 2018 Jul 12;61(13):5719-5732; Carrasco K. et al., J. Med. Chem. 2022 Apr 14;65(7):5660-5674 

2 Hoffer L., et al. J. Chem. Inf. Model. 2019 2019 Apr 22;59(4):1472-1485

Current news

category
Software
SeeSAR 13: ‘Midas’ — Tangible Merit
May 15, 2023 09:58 CEST
Enter the next stage of modern and sophisticated drug discovery with SeeSAR ‘Midas’. Version 13 has been developed as a powerful and user-friendly tool for the generation of goal-oriented results — with a single click! Midas comes with a novel ideation engine that we call ‘MedChemesis’: A ligand mutation tool...
Read on
category
Software
April 2023 Update of Enamine's REAL Space
April 28, 2023 15:31 CEST
We are proud to share the latest update of Enamine’s REAL Space. The version comes with an additional set of over 300 million novel compounds approaching 37 billion of commercially available compounds. Enamine excels in delivering your compounds of interest within few weeks with noteworthy purity. One of the key...
Read on
A Chat with BioSolvers from the States — Challenges and Opportunities
April 17, 2023 14:04 CEST
Drug discovery is slowly but steadily transforming. A key factor contributing to that is the evolution of computational drug discovery solutions in the past decade that are now an integral part of all stages of research and development. Yet, novel methods and innovations in general come with their own challenges...
Read on